Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

RSS icon
Biosense Webster CARTO 3 System Version 8

Biosense Webster updates 3D heart mapping software with advanced AI models

The update includes multiple new algorithms designed to improve efficiency during cardiac ablation procedures.

When Apple previewed its watchOS 9 update in early June, one of the key features the company highlighted was a new tracking option for atrial fibrillation (AFib) patients. The AFib History feature, approved for patients 22 years and older who have been diagnosed with AFib, was designed to help users gain a better understanding of their symptoms and easily share data with healthcare providers.

Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices

Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.

Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF

Researchers explored data from nearly 2,500 AFib ablation patients, sharing their findings in JAMA Cardiology.

pharmaceutical drug approval process

American Heart Association thinks pharmacists can play a bigger role in AFib care

Pharmacists interact with patients on a regular basis and are seen as a trusted source of health information. Can they help cardiologists improve care for AFib patients? 

2 out of 5 AFib patients develop heart failure later in life

Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.

pharmaceutical drug approval process

FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy

The new gene therapy candidate is now one step closer to being approved by the FDA. 

First look at data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH SF platform for atrial fibrillation presented at EHRA Congress

The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is the first dual energy pulsed field (PF) ablation / radiofrequency (RF) ablation catheter integrated with a PF and RF ablation index.

Osso VR, a San Francisco-based virtual reality (VR) company, has developed a new VR training simulation focused on left atrial appendage occlusion (LAAO) procedures. The simulation is designed to offer clinicians a new way to practice LAAO procedures in a “repeatable, risk-free virtual environment.”

Cardiologist-approved VR for interventional procedures headed to ACC.24

San Francisco-based Osso VR and the American College of Cardiology have collaborated on advanced LAAO simulations. The two groups first started working together back in 2022. 

Displaying 81 - 88 of 311
Design by Adaptive Theme